Study to Evaluate the Effect of Nicotinamide Mononucleotide (NMN) As an Adjuvant to Standard of Care (SOC) On Fatigue Associated With COVID-19 Infection

Stopped Required criteria of covid patient was not met

Conditions

• COVID-19 Infection

Interventions

• OTHER: Nicotinamide Mononucleotide
• OTHER: Nicotinamide Mononucleotide with L-Leucine
• OTHER: Placebo

Sponsor

Vedic Lifesciences Pvt. Ltd.

Collaborators

• [object Object]